Track topics on Twitter Track topics that are important to you
Agendia Inc. raised $35mm through a late-stage round from funds managed by Athyrium Capital Management. Agendia markets DNA microarray-based molecular diagnostics and will use some of the funds to sup...
(Weber Shandwick) Agendia, Inc., a world leader in precision oncology, announced today that US Oncology Research, one of the nation's largest research networks dedicated to bringing cutting-edge treat...
Agendia, located in Amsterdam, The Netherlands, is a world leader in gene expression analysis-based diagnostics with three products on the market. The company focuses on the development and commer...
Agendia is a privately owned, leading molecular diagnostic company that develops and markets FFPE-based genomic diagnostic products, which help support physicians with their compl...
Agendia is at the forefront of the personalized medicine revolution, striving to bring more effective, individualized treatment within reach of patients. Building on a cutting edge genomics platform f...
We have published hundreds of Agendia, Inc. news stories on BioPortfolio along with dozens of Agendia, Inc. Clinical Trials and PubMed Articles about Agendia, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Agendia, Inc. Companies in our database. You can also find out about relevant Agendia, Inc. Drugs and Medications on this site too.
Molecular diagnostics is a technique used to analyse biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing. The tec...
Track and monitor developments in breast cancer research and commercial development. Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...